Post by the Scribe on May 25, 2021 23:58:12 GMT
Stronger Together: Neurolex develops a “vocal biomarker” to rapidly screen for COVID-19
Microsoft for Startups
14.6K subscribers
CEO Jim Schwoebel founded Neurolex www.neurolex.ai/
after his brother experienced a psychotic episode, and noticed that his voice changed. Boston-based Neurolex has developed “vocal biomarkers” to detect mental health issues, and with the advent of the coronavirus pandemic is working to adapt the technology to identify COVID-19 symptoms using only a voice recording. In this interview, hear how Neurolex has scaled to meet 10x demand under stringent security and compliance requirements.
Learn more about SurveyLex, Neurolex’s voice survey product, at www.surveylex.com/
Find more stories at aka.ms/StartupStrong
#StartupStrong